Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Taguchi

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
International Journal of Molecular Sciences|June 12, 2026
Clinical Outcomes and Exploratory Longitudinal CTL/Vβ Repertoire Remodeling in Patients with Relapsed or Refractory Large B-Cell Lymphoma and Follicular Lymphoma Treated with EpcoritamabTatsuro Jo, Jun Taguchi, Yasushi Sawayama, et al.
International Journal of Clinical Oncology|July 5, 2014
Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinomaTakatsugu Mizumachi, Akihiro Homma, Tomohiko Kakizaki, et al.
Blood|April 29, 2015
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasmTomohiro Aoki, Ritsuro Suzuki, Yachiyo Kuwatsuka, et al.
Internal Medicine (Tokyo, Japan)|March 12, 2015
The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasonsMaki Baba, Tomoko Hata, Hideki Tsushima, et al.
Leukemia Research|May 4, 2012
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: serial monitoring after allogeneic stem cell transplantation for acute leukemiaTakuya Miyazaki, Hiroyuki Fujita, Katsumichi Fujimaki, et al.
Leukemia Research Reports|May 8, 2019
Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with <i>MYC</i> locus rearrangementTakeharu Kato, Hidehiro Itonaga, Jun Taguchi, et al.
Cancer Science|December 18, 2022
EGFR inhibition in EGFR-mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironmentAkihiko Shiiya, Takuro Noguchi, Utano Tomaru, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of ageHirotaka Takasaki, Chizuko Hashimoto, Atsuko Fujita, et al.
Transplant Immunology|May 31, 2021
The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group ExperienceMachiko Fujioka, Hidehiro Itonaga, Takafumi Furumoto, et al.
The Lancet. Haematology|March 8, 2016
Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation studyMichinori Ogura, Yoshitaka Imaizumi, Naokuni Uike, et al.
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
International Journal of Molecular Sciences|June 12, 2026
Clinical Outcomes and Exploratory Longitudinal CTL/Vβ Repertoire Remodeling in Patients with Relapsed or Refractory Large B-Cell Lymphoma and Follicular Lymphoma Treated with EpcoritamabTatsuro Jo, Jun Taguchi, Yasushi Sawayama, et al.
International Journal of Clinical Oncology|July 5, 2014
Feasibility and efficacy of induction docetaxel, cisplatin, and 5-fluorouracil chemotherapy combined with concurrent weekly cisplatin chemoradiotherapy for locally advanced head and neck squamous cell carcinomaTakatsugu Mizumachi, Akihiro Homma, Tomohiko Kakizaki, et al.
Blood|April 29, 2015
Long-term survival following autologous and allogeneic stem cell transplantation for blastic plasmacytoid dendritic cell neoplasmTomohiro Aoki, Ritsuro Suzuki, Yachiyo Kuwatsuka, et al.
Internal Medicine (Tokyo, Japan)|March 12, 2015
The level of bone marrow WT1 message is a useful marker to differentiate myelodysplastic syndromes with low blast percentage from cytopenia due to other reasonsMaki Baba, Tomoko Hata, Hideki Tsushima, et al.
Leukemia Research|May 4, 2012
Clinical significance of minimal residual disease detected by multidimensional flow cytometry: serial monitoring after allogeneic stem cell transplantation for acute leukemiaTakuya Miyazaki, Hiroyuki Fujita, Katsumichi Fujimaki, et al.
Leukemia Research Reports|May 8, 2019
Successful outcome of second allogeneic bone marrow transplantation for blastic plasmacytoid dendritic cell neoplasm with <i>MYC</i> locus rearrangementTakeharu Kato, Hidehiro Itonaga, Jun Taguchi, et al.
Cancer Science|December 18, 2022
EGFR inhibition in EGFR-mutant lung cancer cells perturbs innate immune signaling pathways in the tumor microenvironmentAkihiko Shiiya, Takuro Noguchi, Utano Tomaru, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Upfront autologous stem cell transplantation for untreated high-risk diffuse large B-cell lymphoma in patients up to 60 years of ageHirotaka Takasaki, Chizuko Hashimoto, Atsuko Fujita, et al.
Transplant Immunology|May 31, 2021
The response-guided ATG treatment provides a survival benefit and KPS recovery for patients with steroid refractory acute GVHD: The Nagasaki Transplant Group ExperienceMachiko Fujioka, Hidehiro Itonaga, Takafumi Furumoto, et al.
The Lancet. Haematology|March 8, 2016
Lenalidomide in relapsed adult T-cell leukaemia-lymphoma or peripheral T-cell lymphoma (ATLL-001): a phase 1, multicentre, dose-escalation studyMichinori Ogura, Yoshitaka Imaizumi, Naokuni Uike, et al.
Pageof 16